A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
- 18 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Microbiology
- Vol. 5 (8), 1040-1050
- https://doi.org/10.1038/s41564-020-0723-z
Abstract
The rapid emergence and dissemination of multidrug-resistant (MDR) bacterial pathogens pose a serious threat to global healthcare. One particular concern is the carbapenem-resistant Enterobacteriaceae (CRE), a group of Gram-negative bacteria that have evolved resistance to all or nearly all available antibiotics. Coupled with the fact of barren antibiotic development pipeline nowadays, a critical approach is to revitalize existing antibiotics using antibiotic adjuvants. We found a short linear antibacterial peptide (SLAP)-S25 carrying four non-natural amino acids of 2,4-diaminobutanoic acid (Dab), which solely showed weak antibacterial activity but boosted the efficacy of antibiotics covering all major classes, including cefepime, colistin, ofloxacin, rifampicin, tetracycline and vancomycin, against MDR Gram-negative pathogens. Mechanistic studies showed that SLAP-S25 triggers membrane damage by binding to both lipopolysaccharide (LPS) in the outer membrane and phosphatidylglycerol (PG) in bacterial cytoplasmic membrane, to potentiate antibiotic efficacy through collaborative strategies. Lastly, SLAP-S25 effectively enhanced the activity of colistin against MDR Escherichia coli-associated infections in three animal models. Our findings provide a potential therapeutic option using existing antibiotics in combination with broad-spectrum antibiotic adjuvants, to address the prevalent infections caused by MDR Gram-negative pathogens worldwide.This publication has 50 references indexed in Scilit:
- Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS productionNature Biotechnology, 2013
- Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative BacteremiaClinical Infectious Diseases, 2012
- Hospital-Acquired Infections Due to Gram-Negative BacteriaThe New England Journal of Medicine, 2010
- An outer membrane protease of the omptin family prevents activation of the Citrobacter rodentium PhoPQ two‐component system by antimicrobial peptidesMolecular Microbiology, 2009
- Structure of glycerol-3-phosphate dehydrogenase, an essential monotopic membrane enzyme involved in respiration and metabolismProceedings of the National Academy of Sciences of the United States of America, 2008
- GlpD and PlsB Participate in Persister Cell Formation in Escherichia coliJournal of Bacteriology, 2006
- Identification and Partial Characterization of the Nonribosomal Peptide Synthetase Gene Responsible for Cereulide Production in Emetic Bacillus cereusApplied and Environmental Microbiology, 2005
- Structure and Mechanism of the Glycerol-3-Phosphate Transporter from Escherichia coliScience, 2003
- Lipopolysaccharide EndotoxinsAnnual Review of Biochemistry, 2002
- Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerusAntimicrobial Agents and Chemotherapy, 1977